Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

AZN - Astrazeneca plc - ADR

IEX Last Trade
87.62
0.320   0.365%

Share volume: 2,836,761
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$87.30
0.32
0.37%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
50%
Profitability 34%
Dept financing 44%
Liquidity 48%
Performance 69%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.11%
1 Month
13.86%
3 Months
15.54%
6 Months
35.73%
1 Year
32.80%
2 Year
48.31%
Key data
Stock price
$87.62
P/E Ratio 
42.19
DAY RANGE
N/A - N/A
EPS 
$2.06
52 WEEK RANGE
$57.94 - $87.68
52 WEEK CHANGE
$0.34
MARKET CAP 
271.671 B
YIELD 
1.68%
SHARES OUTSTANDING 
3.101 B
DIVIDEND
$0.50
EX-DIVIDEND DATE
08/09/2024
NEXT EARNINGS DATE
11/12/2024
BETA 
0.39
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,494,404
AVERAGE 30 VOLUME 
$4,531,517
Company detail
CEO: Pascal Soriot
Region: US
Website: https://www.astrazeneca.com/
Employees: 83,500
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

Recent news